Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Mar 2026 for SynAct Pharma AB, €2,517.
Filing timeline
BuySaleMads Liebach Bjerregaard
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Mads Liebach Bjerregaard: trading record in brief
Only one filing by Mads Liebach Bjerregaard is known so far (9 March 2026): an open-market purchase, €2,517, in SynAct Pharma AB. That is too little to draw conclusions. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Mads Liebach Bjerregaard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 1,500 shares@ €1.6780.0029% mcap100.0% of flowAktieISIN SE0008241491FI:A003W835-1Canonical exit: 3 Jun 2026 (T+90)
1 of 1 declaration